Additionally, MSCs modulate the expression and availability of glucose transporters in the plasma membrane, such as GLUT4 in skeletal muscle, adipose tissue, and liver, thereby reducing peripheral insulin resistance [23, 24]. The gene discussed is SLC2A4; the disease is Insulin resistance.